Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Barrett Esophagus 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Lung Diseases 1Hypoxia 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Breast Neoplasm Female 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 19Pemetrexed 10Paclitaxel 7pembrolizumab 5Nivolumab 5Cisplatin 5Gemcitabine 4osimertinib 3entinostat 3camrelizumab 3atezolizumab 3Erlotinib Hydrochloride 3zipalertinib 2selpercatinib 2pralsetinib 2durvalumab 2apatinib 2Vinorelbine 2Surveys and Questionnaires 2One-Lung Ventilation 2Ipilimumab 2Docetaxel 2Bevacizumab 2130-nm albumin-bound paclitaxel 2zimberelimab 1toripalimab 1spartalizumab 1sotorasib 1sitravatinib 1sintilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Diseases × Diagnostic Imaging × Clear all
NCT03704870 2020-05-01

Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection

University Health Network, Toronto

Phase 2 Completed
50 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡